1. Home
  2. ACGLN vs SRPT Comparison

ACGLN vs SRPT Comparison

Compare ACGLN & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACGLN
  • SRPT
  • Stock Information
  • Founded
  • ACGLN N/A
  • SRPT 1980
  • Country
  • ACGLN Bermuda
  • SRPT United States
  • Employees
  • ACGLN 5800
  • SRPT N/A
  • Industry
  • ACGLN Property-Casualty Insurers
  • SRPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACGLN Finance
  • SRPT Health Care
  • Exchange
  • ACGLN Nasdaq
  • SRPT Nasdaq
  • Market Cap
  • ACGLN N/A
  • SRPT N/A
  • IPO Year
  • ACGLN N/A
  • SRPT 1997
  • Fundamental
  • Price
  • ACGLN $16.91
  • SRPT $37.60
  • Analyst Decision
  • ACGLN
  • SRPT Buy
  • Analyst Count
  • ACGLN 0
  • SRPT 23
  • Target Price
  • ACGLN N/A
  • SRPT $125.43
  • AVG Volume (30 Days)
  • ACGLN N/A
  • SRPT 5.9M
  • Earning Date
  • ACGLN N/A
  • SRPT 05-06-2025
  • Dividend Yield
  • ACGLN N/A
  • SRPT N/A
  • EPS Growth
  • ACGLN N/A
  • SRPT N/A
  • EPS
  • ACGLN N/A
  • SRPT N/A
  • Revenue
  • ACGLN N/A
  • SRPT $2,233,371,000.00
  • Revenue This Year
  • ACGLN N/A
  • SRPT $39.01
  • Revenue Next Year
  • ACGLN N/A
  • SRPT $13.35
  • P/E Ratio
  • ACGLN N/A
  • SRPT N/A
  • Revenue Growth
  • ACGLN N/A
  • SRPT 59.15
  • 52 Week Low
  • ACGLN N/A
  • SRPT $34.10
  • 52 Week High
  • ACGLN N/A
  • SRPT $173.25
  • Technical
  • Relative Strength Index (RSI)
  • ACGLN 46.20
  • SRPT 33.31
  • Support Level
  • ACGLN $16.74
  • SRPT $36.89
  • Resistance Level
  • ACGLN $17.09
  • SRPT $39.56
  • Average True Range (ATR)
  • ACGLN 0.22
  • SRPT 2.14
  • MACD
  • ACGLN 0.01
  • SRPT 0.95
  • Stochastic Oscillator
  • ACGLN 34.69
  • SRPT 34.86

About ACGLN Arch Capital Group Ltd.

Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: